MedTrace Logo

Period Pills for Menstrual Regulation: A New Reproductive Health Option

NCT07671989 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-06-26

No results posted yet for this study

Summary

The Period Pills Study is a prospective observational study among people who decide to use a combination of mifepristone and misoprostol for menstrual regulation.

Conditions

  • Menstrual Regulation
  • Menstrual Health Intervention

Interventions

DRUG

Mifepristone + Misoprostol

Study participants are given mifepristone and misoprostol for menstrual regulation.

Sponsors & Collaborators

Principal Investigators

  • Ushma D Upadhyay, PhD, MPH · University of California, San Francisco

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-22
Primary Completion
2026-12-31
Completion
2027-05-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07671989 on ClinicalTrials.gov